Skip to main content

Published locations for HAVEN 2: Emicizumab represents new standard of care for hemophilia A with inhibitors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HAVEN 2: Emicizumab represents new standard of care for hemophilia A with inhibitors

User login

  • Reset your password
  • /content/haven-2-emicizumab-represents-new-standard-care-hemophilia-inhibitors
  • /hematologynews/article/153961/bleeding-disorders/haven-2-emicizumab-represents-new-standard-care
  • /pediatricnews/article/153961/bleeding-disorders/haven-2-emicizumab-represents-new-standard-care
  • /hematology-oncology/article/153961/bleeding-disorders/haven-2-emicizumab-represents-new-standard
  • /pediatrics/article/153961/bleeding-disorders/haven-2-emicizumab-represents-new-standard-care